Quick Answer
UNITED THERAPEUTICS Corp reported Common Stock Shares Outstanding of 43.64 million shares for the year ending 2025.
- UNITED THERAPEUTICS Corp showed a decrease of -2.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), UNITED THERAPEUTICS Corp's Common Stock Shares Outstanding has declined by 19.5%.
- Historical annual values: Fiscal year 2025: 43.64 million shares | Fiscal year 2024: 44.83 million shares | Fiscal year 2023: 47.04 million shares | Fiscal year 2022: 46.03 million shares | Fiscal year 2021: 45.11 million shares | Fiscal year 2020: 44.51 million shares | Fiscal year 2019: 43.88 million shares | Fiscal year 2018: 43.59 million shares | Fiscal year 2017: 43.24 million shares | Fiscal year 2016: 42.97 million shares | Fiscal year 2015: 45.76 million shares | Fiscal year 2014: 47.11 million shares | Fiscal year 2013: 50.39 million shares | Fiscal year 2012: 50.17 million shares | Fiscal year 2011: 53.61 million shares | Fiscal year 2010: 57.56 million shares | Fiscal year 2009: 54.22 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: